Transcriptomic changes associated with oral immunotherapy for food allergy
Authors:
Open Access
- 22 March 2024
- journal article
- review article
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 35 (3) , e14106
Abstract
This review summarizes recent advances in characterizing the transcriptional pathways associated with outcomes following Oral Immunotherapy. Recent technological advances including single‐cell sequencing are transforming the ways in which the transcriptional landscape is understood. The application of these technologies is still in its infancy in food allergy but here we summarize current understanding of gene expression changes following oral immunotherapy for food allergy and specific signatures underpinning the different clinical outcomes of desensitization and remission (sustained unresponsiveness). T helper 2A cells have been identified as a cell type which correlates with disease activity and is modified by treatment. Molecular features at study entry may differentiate individuals who achieve more positive outcomes during OIT. Recent findings point to T cell anergy and Type 1 interferon pathways as potential mechanisms supporting redirection of the allergen‐specific immune response away from allergy towards remission. Despite these developments in our understanding of immune mechanisms following OIT, there are still significant gaps. Additional studies examining immune signatures associated with long term and well‐defined clinical outcomes are required to gain a more complete understanding of the pathways leading to remission of allergy, in order to optimize treatments and gain improved outcomes for patients.Keywords
All Related Versions
Funding Information
- National Health and Medical Research Council
- Centre for Food and Allergy Research
This publication has 42 references indexed in Scilit:
- Children and caregiver proxy quality of life from peanut oral immunotherapy trialsClinical and Translational Allergy, 2022
- Memory and naïve gamma delta regulatory T-cell gene expression in the first 24-weeks of peanut oral immunotherapyClinical Immunology, 2021
- Role of orally induced regulatory T cells in immunotherapy and toleranceCellular Immunology, 2020
- Transcriptional changes in peanut-specific CD4+ T cells over the course of oral immunotherapyClinical Immunology, 2020
- Improving Vaccine-Induced Immunity: Can Baseline Predict Outcome?Trends in Immunology, 2020
- Human T Cell Development, Localization, and Function throughout LifeImmunity, 2018
- Regulatory T Cell Reprogramming toward a Th2-Cell-like Lineage Impairs Oral Tolerance and Promotes Food AllergyImmunity, 2015
- Prevalence of challenge-proven IgE-mediated food allergy using population-based sampling and predetermined challenge criteria in infantsJournal of Allergy and Clinical Immunology, 2011
- A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic responseJournal of Allergy and Clinical Immunology, 2011
- Intestinal Tolerance Requires Gut Homing and Expansion of FoxP3+ Regulatory T Cells in the Lamina PropriaImmunity, 2011